Top Stock Gainers Today

TSR, INC. TO BE ACQUIRED BY FOUNDER OF BCFORWARD

News

indianapolis & hauppauge, n.y.--(business wire)--vienna parent corporation, a newly formed special purpose entity (“vienna parent”) formed by justin christian, announced today that it has entered into a definitive agreement to acquire tsr, inc. (“tsr”) (nasdaq: tsri). under the terms of the agreement, vienna acquisition corporation, an affiliate and wholly-owned subsidiary of vienna parent (“vienna sub”), will commence a tender offer to purchase all of the outstanding shares of tsr for $13.40 p.

DEADLINE ACTION ALERT: THE SCHALL LAW FIRM ENCOURAGES INVESTORS IN AST SPACEMOBILE, INC. WITH LOSSES TO CONTACT THE FIRM

News

los angeles, ca / accesswire / may 16, 2024 / the schall law firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ast spacemobile, inc. ("ast spacemobile" or "the company") (nasdaq:asts) for violations of 10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission. investors who purchased the company's securities between november 14, 2023 and april 1, 2024, inclusive (the "class period"), are encouraged to contact the firm before june 17, 2024.

BM TECHNOLOGIES REPORTS FIRST QUARTER 2024 RESULTS

News

revenues and ebitda reflect significant improvement year over year q1 2024 revenue of $16.2 million, net income of $0.7 million q1 2024 core ebitda of $1.4 million radnor, pa / accesswire / may 15, 2024 / bm technologies, inc. (nyse american:bmtx) ("bm technologies", "bmtx", "we", or the "company"), one of the largest digital banking platforms and banking-as-a-service (baas) providers in the country, today reported results for the three months ended march 31, 2024. luvleen sidhu, bmtx's chair, ceo, and founder, stated, "the first quarter of 2024 marked an important turning point in our company's evolution.

CLEVER LEAVES ANNOUNCES VOLUNTARY DELISTING AND SEC DEREGISTRATION

News

tocancipá, colombia, april 26, 2024 (globe newswire) -- clever leaves holdings inc. (nasdaq: clvr, clvrw) (“clever leaves” or the “company”), a global medicinal cannabis company, today announced that its board of directors (the “board”) determined to voluntarily delist its common shares, without par value (the “common shares”) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the “warrants” and together with the common shares, the “securities”) from the nasdaq stock market llc (“nasdaq”) and deregister its securities in order to terminate and suspend its reporting obligations under the securities and exchange act of 1934, as amended (the “exchange act”).

CHEETAH NET SUPPLY CHAIN SERVICE INC. ANNOUNCES CLOSING OF $8.19 MILLION FOLLOW-ON PUBLIC OFFERING

News

charlotte, n.c., may 15, 2024 (globe newswire) -- cheetah net supply chain service inc. (“cheetah net” or the “company”) (nasdaq: ctnt), a supplier of parallel-import vehicles sourced in the u.s. to be sold in the prc market and a logistics and warehouse service provider, today announced the closing of its follow-on offering of 13,210,000 shares of class a common stock. each share of class a common stock was sold at an offering price of $0.62, for gross proceeds of $8.19 million, before deducting placement agent fees and other offering fees and expenses. all the shares of class a common stock were offered by the company.

BIOAFFINITY TECHNOLOGIES REPORTS RECORD Q1 REVENUE DRIVEN BY ACCELERATING GROWTH OF CYPATH® LUNG SALES AND INCREASED LABORATORY VOLUMES

News

san antonio--(business wire)-- #biaf--bioaffinity technology reports record q1 2024 revenue driven by accelerating sales of lung cancer diagnostic cypath lung.

MAXEON SOLAR TECHNOLOGIES, LTD. BEING INVESTIGATED ON BEHALF OF MAXEON SOLAR TECHNOLOGIES, LTD.

News

new york, ny / accesswire / may 16, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of maxeon solar technologies, ltd. ("maxeon solar technologies, ltd.

MAGNITE TO PARTICIPATE IN UPCOMING FINANCIAL CONFERENCES

News

new york, may 13, 2024 (globe newswire) -- magnite (nasdaq: mgni), the largest independent sell-side advertising company, today announced that members of its executive team will participate and host in-person investor meetings at the following financial conferences:

LM FUNDING AMERICA, INC. ACHIEVES OVER 105% YEAR-OVER-YEAR REVENUE GROWTH TO $4.7 MILLION AND GENERATED $1.9 MILLION OF NET INCOME FOR THE FIRST QUARTER OF 2024

News

mined 86.4 bitcoins in q1 2024 valued at approximately $4.6 million at an average  market revenue value of approximately $53,000 per bitcoin

NANOVIRICIDES HAS FILED ITS QUARTERLY REPORT

News

nv-387 advancing to phase ii clinical trial for the treatment of rsv infection shelton, ct / accesswire / may 15, 2024 / nanoviricides, inc. (nyse american:nnvc) (the "company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its quarterly report on form 10-q for the fiscal second quarter ending march 31, 2024 with the securities and exchange commission (sec) on tuesday, may 14, 2024. the report can be accessed at the sec website by searching for the company's filings.

TRUPANION PRIMED AND READY TO PROVIDE COVERAGE FOR LIFESAVING MEDICATION FOR FELINE INFECTIOUS PERITONITIS

News

seattle--(business wire)--trupanion (nasdaq: trup), the leading provider of medical insurance for cats and dogs, is poised to increase access for trupanion members to lifesaving medications for treatment of otherwise deadly feline infectious peritonitis (fip). trupanion has been providing coverage where the medications are already commercially available in australia and canada and is ready to continue fighting fip in the united states in june. the covid pandemic spurred a slew of new medical re.

ATHIRA PHARMA REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PIPELINE AND BUSINESS UPDATES

News

topline data from phase 2/3 lift-ad clinical trial of fosgonimeton as a potential treatment for mild-to-moderate alzheimer's disease expected in second half of 2024  submitted investigational new drug application to u.s. food and drug administration for ath-1105 for the treatment of amyotrophic lateral sclerosis; on track to dose subjects in a first-in-human study in second quarter of 2024 strong balance sheet to support innovative pipeline through key clinical inflection points bothell, wash., may 15, 2024 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today reported financial results for the quarter ended march 31, 2024, and provided recent pipeline and business updates.

LUMOS PHARMA ANNOUNCES POSITIVE END-OF-PHASE 2 MEETING WITH FDA AND REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

outcome from end-of-phase 2 meeting supportive of a placebo-controlled phase 3 trial updated 12 and 24-month data from phase 2 oragrowth210 and oragrowth212 trials continue to show oral lum-201 achieves significant increase in growth from baseline, durable effect to 24 months company to host conference call may 15, 2024, at 8:30am et austin, texas, may 14, 2024 (globe newswire) -- lumos pharma, inc. (nasdaq:lumo), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, today announced the outcome from its end-of-phase 2 meeting with the fda, provided a clinical programs update, and reported financial results for the quarter ended march 31, 2024. "we are pleased to announce that, earlier this quarter, we had a very productive end-of-phase 2 meeting with the fda," said rick hawkins, chairman and ceo of lumos pharma.

FIREFLY NEUROSCIENCE, AN AI-DRIVEN BRAIN HEALTH COMPANY, APPOINTS HEALTHCARE-INDUSTRY EXECUTIVE, DAVID JOHNSON AS EXECUTIVE CHAIRMAN, UPON CLOSING OF ITS MERGER TRANSACTION WITH WAVEDANCER

News

fairfax, va. and toronto, may 14, 2024 (globe newswire) -- firefly neuroscience, inc. (“firefly”), a pioneering artificial intelligence (“ai”) company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the appointment of david johnson as its executive chairman upon closing of its planned merger with wavedancer, inc. (“wavedancer”) (nasdaq: wavd). firefly has entered into a definitive agreement and plan of merger (as amended, the “merger agreement”) with wavedancer, which has been approved by the stockholders of both companies and both companies are working towards meeting the final closing conditions.

VENTYX BIOSCIENCES ANNOUNCES APPOINTMENT OF MATTHEW MOORE AS CHIEF OPERATING OFFICER

News

san diego, may 16, 2024 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx), (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced the appointment of industry veteran matthew moore as chief operating officer.

U POWER ANNOUNCES FILING OF 2023 ANNUAL REPORT WITH THE SEC

News

shanghai , may 16, 2024  /prnewswire/ -- u power limited (nasdaq: ucar) (the "company" or "u power"), a vehicle sourcing services provider with a vision to becoming a comprehensive electric ev battery power solution provider in china, today announces that on may 15, 2024, the company filed its 2023 annual report (20-f) with the u.s. securities and exchange commission (the "sec"). 2023 financial highlights total net revenues increased by 153.5% year over year to rmb19.8 million (us$2.8 million) in 2023.

INSEEGO REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

san diego--(business wire)---- $insg #5gstocks--inseego reports first quarter 2024 financial results.

ZURA BIO ANNOUNCES OVERSUBSCRIBED $112.5 MILLION PRIVATE PLACEMENT

News

henderson, nev.--(business wire)--zura bio limited (nasdaq: zura) (“zura bio”), a clinical stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today announced that it has entered into subscription agreements for a private placement that is expected to result in gross proceeds of approximately $112.5 million, before deducting placement agent fees and offering expenses (the “private placement”). the private placement is led by a.

RENT THE RUNWAY, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 RESULTS

News

exceeded revenue and adjusted ebitda guidance for q4 2023 expect revenue growth in fy 2024 through focus on marketing, product innovation and strong customer retention. committed to achieving free cash flow breakeven for fy 2024.

ELEDON PHARMACEUTICALS REPORTS FIRST QUARTER 2024 OPERATING AND FINANCIAL RESULTS

News

completed oversubscribed $50 million private placement first participant dosed in clinical trial at university of chicago medicine assessing the use of tegoprubart to prevent islet cell transplant rejection in patients with type 1 diabetes reported updated data from ongoing phase 1b trial evaluating tegoprubart for prevention of rejection in kidney transplantation tegoprubart used as part of immunosuppressive treatment following the first-ever kidney xenotransplant irvine, calif., may 09, 2024 (globe newswire) -- eledon pharmaceuticals, inc. (“eledon”) (nasdaq: eldn) today reported its first quarter 2024 operating and financial results and reviewed recent business highlights.

TFF PHARMACEUTICALS PROVIDES UPDATE ON TACROLIMUS INHALATION POWDER (TFF TAC) PHASE 2 TRIAL FOR THE PREVENTION OF LUNG TRANSPLANT REJECTION

News

patient enrollment has accelerated with now 10 patients enrolled in phase 2 trial 6 out of 6 patients who completed the 12-week treatment have chosen to remain on tff tac by proceeding to the safety extension phase; 1 patient has been treated for over a year and 3 additional patients have been treated for more than 6 months variability in systemic exposure to tacrolimus was reduced with tff tac which could lower risk of acute rejection and systemic toxicities fort worth, texas, may 15, 2024 (globe newswire) -- tff pharmaceuticals, inc. (nasdaq: tffp) (“the company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented thin film freezing (tff) technology platform, today provided an update from the company's ongoing phase 2 trial of tacrolimus inhalation powder (tff tac) for the prevention of lung transplant rejection. “i am pleased to report that patient enrollment has accelerated due to positive physician enthusiasm based on emerging data, and we have now enrolled 10 patients in the tff tac phase 2 study,” said dr. harlan weisman, chief executive officer of tff pharmaceuticals.

CUMULUS MEDIA WELCOMES THE CANDY VALENTINO SHOW TO THE CUMULUS PODCAST NETWORK

News

new york, may 08, 2024 (globe newswire) -- cumulus media (nasdaq: cmls) today announced the candy valentino show has joined the cumulus podcast network. entrepreneur and bestselling author candy valentino talks with some of the world's most successful minds, including tony robbins, daymond john, ed mylett, and heidi zak, while offering valuable insights drawn directly from her 26 years of expertise launching and selling her own businesses. she discusses wealth habits, business models, profit plans, real estate investing, and much more to help listeners achieve security and wealth.

IREN REPORTS THIRD QUARTER FY24 RESULTS

News

achieved record revenue, adjusted ebitda and operating cashflow $47.9 million operating cash inflow in fy24 ytd quarterly npat of $8.6 million expansion to 30 eh/s in 2024 sydney, australia, may 15, 2024 (globe newswire) -- iren (iris energy limited) (nasdaq: iren) (together with its subsidiaries, "iren" or “the company”), a leading next-generation data center business powering the future of bitcoin, ai and beyond, today reported its financial results for the three-months and nine-months ended march 31, 2024. all $ amounts are in united states dollars (“usd”) unless otherwise stated.

CASTOR MARITIME INC. EXTENDS TENDER OFFER TO PURCHASE ITS OUTSTANDING COMMON SHARE PURCHASE WARRANTS ISSUED ON APRIL 7, 2021

News

limassol, cyprus, may 16, 2024 (globe newswire) -- castor maritime inc. (nasdaq: ctrm), (“castor” or the “company”), a diversified global shipping company, announces today that it has extended the expiration date of its previously announced tender offer (the “offer”) to purchase all of its outstanding common share purchase warrants issued on april 7, 2021 (the “warrants”). the offer is now scheduled to expire at 5:00 p.m. eastern time on may 31, 2024, unless further extended.

SABLE OFFSHORE CORP. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATES

News

houston--(business wire)--sable offshore corp. reports first quarter 2024 financial results and provides operational updates.

UNIFI®, MAKERS OF REPREVE®, ANNOUNCES SEVENTH ANNUAL CHAMPIONS OF SUSTAINABILITY AWARD WINNERS

News

greensboro, n.c.--(business wire)--unifi, inc. (nyse: ufi) (together with its consolidated subsidiaries, “unifi”), the makers of repreve and one of the world's leading innovators in recycled and synthetic yarns, today announced its seventh annual repreve champions of sustainability award recipients. these annual awards celebrate the industry pioneers who have recycled over 40 billion plastic bottles into new products through repreve. unifi applauds the following partners as leading stewards of.

GENEDX REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

News

reported first quarter 2024 revenue from continuing operations 1 of $61.5m with 96% year-over-year growth of exome and genome test revenue expanded first quarter 2024 adjusted gross margins 2 from continuing operations to 61% narrowed first quarter 2024 adjusted net loss 2 to $8.5m and delivered 71% year-over-year cash burn reduction raised guidance to deliver between $235m and $245m in fy 2024 revenue and reiterate path to profitability in 2025 genedx to host conference call today at 4:30 p.m. et stamford, conn.

ORIGIN AGRITECH REPORTS STRONG FINANCIAL RESULTS FOR THE FIRST HALF OF FY2024 AND HIGHLIGHTS SIGNIFICANT ADVANCEMENTS IN GMO CORN APPROVAL

News

beijing , may 15, 2024 /prnewswire/ -- origin agritech ltd. (nasdaq: seed) (the "company" or "origin"), a leading chinese agricultural technology company, today announced its unaudited financial results for the six months ended march 31, 2024.

FLYEXCLUSIVE REPORTS FULL YEAR 2023 FINANCIAL RESULTS

News

kinston, n.c.--(business wire)--flyexclusive, llc. (nyseamerican:flyx) today announced full year 2023 financial results through a form 10-k furnished with the securities and exchange commission (sec). the form 10-k can be found at https://ir.flyexclusive.com/sec-filings or at www.sec.gov. management will discuss these results during a conference call being held today at 5:00 pm et. interested parties can access the conference call by dialing 877-404-1250 or +1 215-268-9892. to access a live web.

DIGITAL HEALTH ACQUISITION CORP. ANNOUNCES LISTING TRANSFER TO THE NASDAQ CAPITAL MARKET

News

boca raton, fl, oct. 27, 2023 (globe newswire) -- digital health acquisition corp. (the “company” or “digital health”) (nasdaq: dhac), announced today that it received approval from the nasdaq stock market (“nasdaq”) to transfer the listing of its securities (including the common stock, units, and warrants) (the “securities”) from the nasdaq global market to the nasdaq capital market. the company's common stock, units and warrants will continue to trade under the symbols “dhac,” “dhacu” and “dhacw,” respectively and the trading of its securities will be unaffected by this transfer. this transfer will be effective as of the opening of business on october 30, 2023.

CAPITAL INJECTION AND ROBUST MARGINS POSITION XOS, INC. FOR A STRONG 2024

News

improved cash position with $50 million from acquisition of electrameccanica delivered 180% year-over-year revenue growth achieved industry-leading 21% gross margins los angeles, ca / accesswire / may 15, 2024 / xos, inc. (nasdaq:xos) ("xos" or the "company"), a leading electric truck manufacturer and fleet services provider, today reported financial results for the first quarter ended march 31, 2024. first quarter 2024 highlights: completed acquisition of electrameccanica, adding approximately $50.2 million (excluding certain costs paid at closing) to xos' cash balance launched the updated xos hub mobile charging solution delivered 62 units and generated revenues of $13.2 million achieved gross margins of 21.2% dakota semler, chief executive officer of xos, commented, "the $50 million that we secured this quarter and our industry-leading gross margins position xos for a strong future.

SHAREHOLDER INVESTIGATION: HALPER SADEH LLC INVESTIGATES SBOW, CRGY

News

new york , may 16, 2024 /prnewswire/ -- halper sadeh llc, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: silverbow resources, inc. (nyse: sbow)'s  sale to crescent energy company. under the terms of the proposed transaction, silverbow shareholders would receive 3.125 shares of crescent class a common stock for each share of silverbow common stock, with the option to elect to receive all or a portion of the proceeds in cash at a value of $38 per share, subject to possible pro ration with a maximum total cash consideration for the transaction of $400 million.

SEANERGY MARITIME REPORTS RECORD FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 31, 2024 AND DECLARES CASH DIVIDENDS OF $0.15 PER SHARE

News

highlights     (in million usd, except eps)   q1 2024 q1 2023 net revenues   $38.3 $18.0   net income / (loss)   $10.2 ($4.2)   adjusted net income1 / (loss)   $11.6 ($0.4)   ebitda1   $21.6 $8.2   adjusted ebitda1   $23.2 $3.9           earnings / (loss) per share basic & diluted   $0.50 ($0.23)   adjusted earnings / (loss) per share basic1   $0.58 ($0.02)   adjusted earnings / (loss) per share diluted1   $0.57 ($0.02)   other highlights and developments: record first quarter net income of $10.2 million cash dividends of $0.15 per share consisting of a quarterly cash dividend of $0.025 per share for q1 2024 and a special cash dividend of $0.125 per share total cash dividends of $1.60 per share, or $29.6 million, declared since march 2022 acquisition of two japanese capesize vessels, built in 2013 and 2012, with estimated deliveries in q2 and h2 2024, respectively new financing and refinancing transactions of $58.3 million athens, greece, may 15, 2024 (globe newswire) -- seanergy maritime holdings corp. (“seanergy” or the “company”) (nasdaq: ship), announced today its financial results for the first quarter ended march 31, 2024. the company also declared a quarterly cash dividend of $0.025 per common share and a special cash dividend of $0.125 per common share for the first quarter of 2024.

CG ONCOLOGY REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES

News

cretostimogene monotherapy demonstrated 75.2% complete response (cr) rate at any time in bacillus calmette guerin (bcg)-unresponsive, high-risk non-muscle invasive bladder cancer (hr-nmibc) first patient dosed in pivot-006 phase 3 clinical trial of cretostimogene in intermediate-risk nmibc (ir-nmibc) final results from core-001 phase 2 clinical trial of cretostimogene in combination with pembrolizumab in bcg-unresponsive hr-nmibc will be presented at asco 2024 completed oversubscribed and upsized $437 million initial public offering that extends expected runway through 2027 irvine, calif., may 09, 2024 (globe newswire) -- cg oncology, inc. (nasdaq: cgon), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today reported financial results for the first quarter ended march 31, 2024, and provided business updates.

JUNE 21, 2024 DEADLINE: CONTACT LEVI & KORSINSKY TO JOIN CLASS ACTION SUIT AGAINST GDRX

News

new york, ny / accesswire / may 16, 2024 / if you suffered a loss on your goodrx holdings, inc. (nasdaq:gdrx) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/goodrx-lawsuit-submission-form?prid=80289&wire=1 or contact joseph e. levi, esq.

ESPERION RECEIVES FIVE YEAR PATENT EXTENSION FOR BEMPEDOIC ACID, CONTAINED IN NEXLETOL® AND NEXLIZET®

News

ann arbor, mich., may 14, 2024 (globe newswire) -- esperion (nasdaq: espr) announced today that the u.s. patent and trademark office (uspto) issued a u.s. patent term extension (pte) certificate for bempedoic acid, which is contained in nexletol® (bempedoic acid) tablets and nexlizet® (bempedoic acid and ezetimibe) tablets. the certificate extends the term of u.s. patent no. 7,335,799 by five years through december 3, 2030. the pte certificate was granted under the patent restoration provisions of the drug price competition and patent term restoration act of 1984.

CARECLOUD TO ANNOUNCE FIRST-QUARTER 2024 RESULTS ON MAY 14, 2024

News

somerset, n.j., april 29, 2024 (globe newswire) -- carecloud, inc. (nasdaq: ccld, ccldo, ccldp), a leader in healthcare technology solutions for medical practices and health systems nationwide, will release its financial results for the quarter ended march 31, 2024 before the market opens on tuesday, may 14, 2024. the company will follow with a conference call for investors at 8:30 a.m. eastern time.

PROMIS NEUROSCIENCES ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

News

top-line data from first-in-human phase 1a clinical trial of pmn310 as a treatment for alzheimer's disease on track for mid-2024 top-line data from first-in-human phase 1a clinical trial of pmn310 as a treatment for alzheimer's disease on track for mid-2024

THE CHILDREN'S PLACE REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS

News

secaucus, n.j., may 06, 2024 (globe newswire) -- the children's place, inc. (nasdaq: plce), an omni-channel children's specialty portfolio of brands with an industry-leading digital-first model, today announced financial results for the fourth quarter and fiscal year ended february 3, 2024.

FOGHORN THERAPEUTICS PROVIDES FIRST QUARTER 2024 FINANCIAL AND CORPORATE UPDATE

News

dose escalation in fhd-286 combination trial in aml continues to progress with clinical data expected in the second half of 2024; potential to be a first-in-class oral broad-based differentiation therapeutic in aml

NEXTNAV INC. REPORTS FIRST QUARTER 2024 RESULTS

News

filed rulemaking petition with fcc on april 16, 2024 lays out new vision for complement and backup to gps with additional spectrum for broadband services mclean, va., may 08, 2024 (globe newswire) -- nextnav inc. (nasdaq: nn) (“nextnav” or the “company”) a leader in next generation positioning, navigation, and timing (pnt) and 3d geolocation, today reported financial results for nextnav's first quarter ended march 31, 2024.

EXTREME NETWORKS REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

News

morrisville, n.c.--(business wire)--extreme networks, inc. (“extreme”) (nasdaq: extr) today released financial results for its third quarter ended march 31, 2024. "extreme's focus on the intersection of networking, security, and ai is creating a compelling value proposition that's resonating with customers and driving significant traction in our business. net new logos grew double-digits this quarter, particularly in the americas. our saas arr grew again by 38%, as we continue to deliver on our.

BLACKBOXSTOCKS FILES FORM S-4 FOR EVTEC ACQUISITION

News

reports first quarter financial results for fintech operations dallas, tx, may 16, 2024 – blackboxstocks inc.

IMPERIAL PETROLEUM INC. REPORTS FIRST QUARTER 2024 FINANCIAL AND OPERATING RESULTS

News

athens, greece, may 16, 2024 (globe newswire) -- imperial petroleum inc. (nasdaq: impp, the “company”), a ship-owning company providing petroleum products, crude oil and drybulk seaborne transportation services, announced today its unaudited financial and operating results for the three months ended march 31, 2024.

DIGITAL ALLY, INC ANNOUNCES 2023 OPERATING RESULTS

News

lenexa, kansas, april 02, 2024 (globe newswire) -- digital ally, inc. (nasdaq: dgly) (the “company” or “our”), today announced its operating results for fiscal year 2023. an investor conference call is scheduled for 11:15 a.m. edt on tuesday, april 2, 2024 (see details below).

ARCADIA BIOSCIENCES (RKDA) ANNOUNCES SALE OF GOODWHEATTM TO ABOVE FOOD CORP.

News

dallas--(business wire)--arcadia biosciences, inc.® (nasdaq: rkda), a producer and marketer of innovative, plant-based health and wellness products, and above food corp., an innovative food company leveraging its vertically integrated supply chain to deliver differentiated ingredients and consumer products, announced today that above food will purchase the goodwheattm brand of better-for-you wheat products from arcadia for $4 million net. “we see this as the beginning of a partnership between a.

INVESTIGATION ALERT: THE SCHALL LAW FIRM ANNOUNCES IT IS INVESTIGATING CLAIMS AGAINST MACROGENICS, INC. AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

News

los angeles , may 14, 2024 /prnewswire/ -- the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of macrogenics, inc. ("macrogenics" or "the company") (nasdaq: mgnx) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

UNITED CARGO ADDS CAPACITY TO WEBCARGO BY FREIGHTOS' BOOKING PLATFORM, EXTENDING CARGO SALES PORTAL CAPABILITIES

News

barcelona, spain , may 16, 2024 /prnewswire/ -- freightos (nasdaq: crgo), the vendor-neutral booking and payment platform for the international freight industry, is pleased to expand the collaboration between webcargo by freightos and united cargo (nasdaq: ual). in an industry which is still mostly offline, webcargo is proud to be a key technology partner developing united cargo's state-of-the-art self-service online cargo portal and is proud to further expand this collaboration.

LEAFLY HOLDINGS, INC. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

seattle--(business wire)--leafly holdings, inc. (“leafly” or “the company”) (nasdaq: lfly), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced financial results for its first quarter ended march 31, 2024. "we remain committed to boosting our operational efficiency as we focus on stabilizing revenue and prioritizing ongoing value for our partners," said yoko miyashita, ceo of leafly. “we are excited by the recent historic announcement by the dea.

HAWKINS, INC. REPORTS FOURTH QUARTER AND FISCAL YEAR 2024 RESULTS

News

roseville, minn., may 15, 2024 (globe newswire) -- hawkins, inc. (nasdaq: hwkn), a leading specialty chemical and ingredients company, today announced fourth quarter and full-year results for its fiscal year ended march 31, 2024.

LEVI & KORSINSKY, LLP NOTIFIES SHAREHOLDERS OF NOVAVAX, INC. (NVAX) AN UPCOMING CLAIMS DEADLINE IN A CLASS ACTION SETTLEMENT

News

new york, ny / accesswire / may 16, 2024 / levi & korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against novavax, inc. (nasdaq:nvax). the settlement provides for a fund of $47,000,000 to benefit class members.

CODERE ONLINE REPORTS FINANCIAL RESULTS FOR THE FIRST QUARTER 2024

News

madrid, spain and tel aviv, israel, may 15, 2024 – (globe newswire) codere online (nasdaq: cdro / cdrow, the “company”), a leading online gaming operator in spain and latin america, has released its preliminary unaudited2 financial results for the quarter ended march 31, 2024.

SOW GOOD REPORTS STRONG FIRST QUARTER 2024 RESULTS

News

- q1 revenue increased 20% sequentially to $11.4 million -   - commenced trading on nasdaq on may 2, 2024, marking key corporate milestone -   irving, texas, may 15, 2024 (globe newswire) --  sow good inc. (nasdaq: sowg) (“sow good” or “the company”), a trailblazer in the freeze dried candy and treat industry, is reporting financial and operating results for the first quarter ended march 31, 2024. “we carried our momentum into the first quarter of 2024 and continued to address strong consumer demand for freeze dried candy,” said claudia goldfarb, ceo of sow good.

MAIA BIOTECHNOLOGY ABSTRACT ACCEPTED FOR POSTER PRESENTATION AT AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) 2024 ANNUAL MEETING

News

chicago--(business wire)--maia biotechnology abstract accepted for poster presentation at american society of clinical oncology (asco) 2024 annual meeting.

ALPHA TECHNOLOGY GROUP LIMITED REPORTS 2023 FINANCIAL YEAR RESULTS

News

hong kong , feb. 1, 2024 /prnewswire/ -- alpha technology group limited (the "company" or "alpha")(nasdaq: atgl), a holding company incorporated in the british virgin islands that currently provides cloud-based it solution services through its operating subsidiaries, techlution service limited and neural sense limited (collectively, "operating subsidiaries"), today reported its financial results for the fiscal year ended september 30, 2023. fiscal year 2023 financial highlights: revenues increased by hk$4.27 million (approximately us$0.55 million), or 96.55%, from hk$4.42 million for the year ended september 30, 2022 to hk$8.69 million (approximately us$1.11 million) for the year ended september 30, 2023.

BUZZFEED, INC. FIRST QUARTER 2024 FINANCIAL RESULTS IN LINE WITH MARCH OUTLOOK

News

new york--(business wire)--buzzfeed, inc1.'s (nasdaq: bzfd) reported first quarter (ended march 31, 2024) financial results in line with the company's outlook shared on march 25, 2024. “we closed the first quarter of 2024 with exciting momentum in our business, completing the biggest step in our transformation, which was to refocus the company on our owned and operated sites and apps, and away from the platform-dependent model of distribution,” said jonah peretti, buzzfeed founder & ceo. “t.

ANALYSIS SHOWING LUPKYNIS® IS A COST-EFFECTIVE TREATMENT FOR LUPUS NEPHRITIS PRESENTED AT NATIONAL KIDNEY FOUNDATION'S SPRING CLINICAL MEETING 2024

News

rockville, md. & edmonton, alberta--(business wire)--aurinia pharmaceuticals inc. (nasdaq: auph) (aurinia or the company), today announced the presentation of results from an updated cost-effective analysis of lupkynis (voclosporin), a second generation calcineurin inhibitor (cni), at the annual national kidney foundation (nkf) spring clinical meeting 2024 taking place in long beach, ca, may 14-18. the company will also share additional data from its aurora clinical program. economic modeling b.

THIRD HARMONIC BIO ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

News

u.s. fda clears investigational new drug application for thb335 phase 1 sad/mad clinical trial initiated and subject screening underway,  with results expected during 1h'25 strengthened leadership team with the appointment of christopher j. dinsmore, ph.d.

CANOO TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS

News

justin, tx, may 03, 2024 (globe newswire) -- canoo inc. (nasdaq: goev), a high-tech advanced mobility company, today announced that it will report its financial results for the quarter ended march 31, 2024 after market close on tuesday, may 14, 2024. the company will host a conference call and live webcast at 5:00 pm et to discuss the results, followed by a question-and-answer period.

NRX PHARMACEUTICALS (NASDAQ:NRXP) REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

News

2024 catalysts: positive clinical data, two planned ndas, company launch of hope therapeutics; fda qidp award in cuti and new schizophrenia opportunity executed term sheet from an institutional investor for an initial $7.5 million note, subject to common closing requirements, primarily to replace current debt, clearing the path to a hope therapeutics share distribution, with provision for funding up to $30 million to fund pipeline opportunities positive data from a phase 2b/3 trial of nrx-101 in treatment resistant bipolar depression (trbd); trial demonstrated depression efficacy comparable to standard of care and significant reduction of akathisia (p=0.025). akathisia is a potentially lethal side effect of all serotonin-targeted antidepressants and is associated with suicide.

NCR ATLEOS CORPORATION REPORTS STRONG FIRST QUARTER 2024 RESULTS

News

atlanta--(business wire)--ncr atleos corporation (nyse: natl) (“atleos”) reported financial results today for the three months ended march 31, 2024. first quarter results and other recent highlights include: strong start to 2024 with financial results at or above the high-end of first quarter guidance revenue grew 6% year-over-year to $1.05 billion; recurring revenue grew 7% to a record $763 million adjusted ebitda grew 11% year-over-year to $162 million; adjusted free cash flow1 of $69 million.

CUREVAC ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL-YEAR 2023 AND PROVIDES BUSINESS UPDATE

News

organizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costs together with gsk, ended pandemic preparedness agreement (ppa) with federal republic of germany, after consultation with the german federal ministry of health cash and cash equivalents position of €402.5 million as of december 31, 2023; cash runway extended into q4 2025 with organizational redesign and despite ppa wind-down strategic collaboration signed with world-leading oncology center md anderson, creating unique expertise to jointly discover and develop novel cancer vaccines appointment of thaminda ramanayake as chief business officer, bringing more than 15 years of biopharma company development and deal-making experience promising covid-19 and seasonal flu phase 2 data confirms proprietary mrna platform elicits strong overall antibody titers at well-tolerated dose levels new phase 1/2 study in avian flu started in collaboration with gsk addressing potential future pandemic threat successful safety review of data from glioblastoma phase 1 part a with multiepitope cancer vaccine candidate, cvgbm, enables progressing to part b with expected start mid-2024 curevac to host conference call and webcast today at 9 a.m. et / 3 p.m.

THE BALDWIN GROUP ANNOUNCES SUCCESSFUL PRICING WITH IMPROVED TERMS FOR $840 MILLION TERM LOAN B AND $600 MILLION REVOLVER

News

tampa, fla.--(business wire)--the baldwin group, the go-to-market brand name for the baldwin insurance group, inc. (formerly brp group, inc.) (“baldwin,” “we” or “our”) (nasdaq: brp), today announced that its subsidiary, the baldwin insurance group holdings, llc (“baldwin holdings”), successfully priced a new $840 million senior secured first lien term loan facility maturing on or about may 24, 2031 (the “new term loan facility”) and a new $600 million senior secured first lien revolving facili.

KURA SUSHI GLOBAL FLAGSHIP STORE GINZA TO OPEN ON THURSDAY, APRIL 25, 2024

News

tokyo--(business wire)-- #ginza--kura sushi, inc. (president: kunihiko tanaka; head office: sakai city, osaka), which operates the conveyor-belt sushi chain “kura sushi,” will open “kura sushi global flagship store ginza,” its sixth global flagship store in japan, on thursday, april 25, 2024, inside marronnier gate ginza 2. the store was produced by kashiwa sato, one of japan's top creative directors, and is the first location of a major conveyor-belt sushi chain to open in the ginza area. with the numb.

FIRST WAVE BIOPHARMA, INC. TO RAISE APPROXIMATELY $1.1 MILLION OF GROSS PROCEEDS PRICED AT-THE-MARKET

News

boca raton, fla., may 10, 2024 (globe newswire) -- first wave biopharma, inc., (nasdaq: fwbi), (“first wave biopharma” or the “company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (gi) diseases, announced today that it has entered into a definitive securities purchase agreement with a certain institutional investor for the purchase and sale of 366,000 shares of the company's common stock (or common stock equivalents) at a price of $2.95 per share in a registered direct offering priced at-the-market under nasdaq rules.

EDGIO EMPOWERS VERCARA TO PUSH THE BOUNDARIES OF PERFORMANCE & SECURITY TO THE EDGE

News

phoenix--(business wire)--edgio is pleased to announce that vercara, a leading provider of cloud-based services, has chosen to partner with edgio for their expertise in securing and accelerating web applications. offered by vercara under the brand name ultraedge™, this solution will tap into edgio's new enterprise-level protect and perform applications bundles, a solution that combines tier-1 web performance capabilities with an easy-to-use modern content delivery network (cdn) and a full-spect.

MORPHIC ANNOUNCES CORPORATE HIGHLIGHTS AND FINANCIAL RESULTS FOR THE FIRST QUARTER 2024

News

morf ends 1q24 with $659 million, cash into 2h27; phase 2b study of morf-057 in uc continues on target; anticipate garnet phase 2 in crohn's to begin 2q

RYERSON REPORTS FIRST QUARTER 2024 RESULTS

News

quarterly business highlights include start-up of operations at university park, il service center, completion of erp integration of 17 service centers, and continued investment in organic growth initiatives, including the expansion and modernization of the shelbyville, ky service center chicago , april 30, 2024 /prnewswire/ -- ryerson holding corporation (nyse: ryi), a leading value-added processor and distributor of industrial metals, today reported results for the first quarter ended march 31, 2024. highlights:  earned revenue of $1.24 billion on 497,000 tons shipped and average selling price of $2,493 per ton.

NEPHROS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS

News

full-year net revenue of $14.2 million and fourth-quarter net revenue of $3.3 million south orange, nj, march 07, 2024 (globe newswire) -- via newmediawire – nephros, inc. (nasdaq: neph), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended december 31, 2023. financial highlights fourth quarter ended december 31, 2023 net revenue from continuing operations was $3.3 million, compared to $2.6 million in the fourth quarter of 2022, up 27% net loss from continuing operations was ($0.7 million), approximately equal to the same period in 2022 adjusted ebitda from continuing operations was ($0.1 million), compared to ($0.5 million) in the fourth quarter of 2022, an improvement of 89% year-end 2023 net revenue from continuing operations was $14.2 million, compared with $10.0 million in 2022, up 43% net loss from continuing operations was ($1.6 million), compared with ($4.3 million) in 2022 adjusted ebitda from continuing operations was ($0.1 million), compared with ($2.4 million) in 2022, an improvement of 97% “2023 was an exciting year for nephros.

ANEW MEDICAL ANNOUNCES KEY PATENT ISSUED IN CHINA TO PROTECT KLOTHO PROTEIN AND GENE DELIVERY SYSTEMS

News

new york , march 4, 2024 /prnewswire/ -- anew medical, inc. ("anew" or "the company") (otcpk: leas) a us-based biotechnology company ("anew") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in china, number cn 117126829 a for the use of anew's klotho protein and klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases.

WALMART REPORTS STRONG REVENUE GROWTH OF 6.0% WITH OPERATING INCOME GROWING FASTER AT 9.6%; ADJUSTED OPERATING INCOME UP 13.7%

News

bentonville, ark.--(business wire)--walmart inc. (nyse: wmt): first quarter highlights: consolidated revenue of $161.5 billion, up 6.0%, or 5.8% (in constant currency), including a benefit of ~1% from an additional selling day consolidated gross margin rate up 42bps due to improvements across segments, led by walmart u.s. consolidated operating income up $0.6 billion, or 9.6%; adjusted operating income up 13.7%, due to higher gross margins and growth in membership income global ecommerce sales.

SHAREHOLDER RIGHTS ADVOCATES AT LEVI & KORSINSKY INVESTIGATE FORWARD AIR CORPORATION (FWRD) REGARDING POSSIBLE SECURITIES FRAUD VIOLATIONS

News

new york, ny / accesswire / may 9, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of forward air corporation ("forward air") (nasdaq:fwrd) concerning possible violations of federal securities laws. forward air disclosed its financial performance for the first quarter of 2024, following the market closure on may 8, 2024.

COREBRIDGE FINANCIAL ANNOUNCES FIRST QUARTER 2024 RESULTS

News

houston--(business wire)--corebridge financial, inc. ("corebridge" or the "company") (nyse: crbg) today reported financial results for the first quarter ended march 31, 2024. kevin hogan, president and chief executive officer of corebridge, said, "corebridge had a very strong start to 2024 with operating earnings per share increasing 13% year over year to $1.10. these results demonstrate how our diversified business model delivers multiple sources of income leading to consistent cash flow gener.

UNLEASHING THE POWER OF MAIT CELLS: PLURI LAUNCHES NOVEL IMMUNOTHERAPY PLATFORM FOR SOLID TUMOR CANCER TREATMENT

News

haifa, israel, may 02, 2024 (globe newswire) -- pluri inc. (nasdaq:plur) (tase:plur) ("pluri" or the “company”), a leading biotechnology company that transforms cells into solutions, today launched its placental allogeneic mait cell platform for immunotherapy treatment for solid tumors – a significant medical need which currently lacks effective treatments.

INSZONE INSURANCE SERVICES MARKS 15TH ACQUISITION IN TEXAS WITH ADDITION OF BRAZOS VALLEY INSURANCE AGENCY

News

sacramento, calif.--(business wire)-- #agencyacquisition--inszone insurance services, a rapidly growing national provider of commercial, personal, and benefits insurance, proudly announces its 15th acquisition in the state of texas with the successful integration of brazos valley insurance agency. this strategic move further solidifies inszone's commitment to enhancing its presence in the texas market and marks another significant milestone in the company's ongoing expansion. brazos valley insurance agency was esta.

EXPION360 ANNOUNCES NEW ONLINE RETAIL PARTNERSHIP WITH TRACTOR SUPPLY COMPANY

News

redmond, ore., may 16, 2024 (globe newswire) -- expion360 inc. (nasdaq: xpon) (“expion360” or the “company”), an industry leader in lithium-ion battery power storage solutions, announced a new e-commerce retail partnership with tractor supply company (“tractor supply”), the largest rural lifestyle retailer in the united states, to offer expion360 products online for shipment to customers in 49 states.

VERDE CLEAN FUELS, INC. REPORTS FIRST QUARTER 2024 RESULTS

News

houston--(business wire)--verde clean fuels, inc. (“verde” or the “company”) (nasdaq: vgas), a renewable energy company focused on the development of commercial production facilities to convert syngas derived from diverse feedstocks into gasoline, today reported first quarter 2024 gaap diluted net loss per share of $(0.13). the first quarter net loss consists of ongoing general and administrative and research and development expenses related to the company's continuing focus on development of it.

URGENTLY ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS

News

vienna, va., may 13, 2024 (globe newswire) -- urgent.ly inc. (nasdaq: uly ) (“urgently”), a u.s.-based leading provider of digital roadside and mobility assistance technology and services, today reported financial results for the first quarter ended march 31, 2024.

NEUROBO PHARMACEUTICALS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

News

dosed first patient in the single ascending dose part 1 of the phase 1 clinical trial of da-1726 in obesity, with top-line data readout expected in the third quarter of 2024 anticipate first patient to be dosed in the multiple ascending dose part 2 of the phase 1 clinical trial of da-1726 in the third quarter of 2024 part 2 of the phase 2a trial of da-1241 for the treatment of mash underway after enrollment of part 1 completed, with data expected in the fourth quarter of 2024 cash of $16.0 million, expected to fund the company into the fourth quarter of 2024 cambridge, mass. , may 9, 2024 /prnewswire/ --  neurobo pharmaceuticals, inc. (nasdaq: nrbo), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the first quarter ended march 31, 2024 and provided a corporate update.

FITELL CORPORATION ANNOUNCES FIRST HALF-YEAR FINANCIAL RESULTS

News

taren point, australia, march 05, 2024 (globe newswire) -- fitell corporation (nasdaq: ftel) ("fitell" or the "company"), an online retailer of gym and fitness equipment in australia, today announced its half-year financial results for the six months ended december 31, 2023.

ISPIRE TECHNOLOGY INC. REPORTS FISCAL THIRD QUARTER 2024 FINANCIAL RESULTS

News

total revenue increased 24% year-over-year to $30.0 million gross profit increased 35% year-over-year to $6.1 million north american cannabis vaping hardware revenue increased 57% year-over-year to $11.9 million  closed $12.3 million public offering los angeles , may 14, 2024 /prnewswire/ -- ispire technology inc. ( nasdaq: ispr ) ("ispire" or the "company"), an innovator in vaping technology and precision dosing, today reported results for the fiscal third quarter, which ended march 31, 2024 and filed its quarterly report on form 10-q on may 14, 2024. fiscal third quarter 2024 financial results revenue increased 24% to $30.0 million as compared to $24.1 million in the same period of 2023.

COMSTOCK REPORTS FIRST QUARTER 2024 RESULTS

News

reston, va.--(business wire)--comstock holding companies, inc. (nasdaq: chci) (“comstock” or the “company”), a leading asset manager, developer, and operator of mixed-use and transit-oriented properties in the washington, d.c. region, announced its financial results for the first quarter ended march 31, 2024. “in q1 we achieved comparative revenue growth for the 15th consecutive quarter as expected thanks to versatility of our business model,” said christopher clemente, comstock's chairman and.

ARCA BIOPHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: KAHN SWICK & FOTI, LLC INVESTIGATES MERGER OF ARCA BIOPHARMA, INC. - ABIO

News

new orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed merger of arca biopharma, inc. (the “company”) (nasdaqcm: abio) and oruka therapeutics. upon closing of the proposed transaction, arca shareholders are expected to own approximately 2.38% of the combined company. ksf is seeking to determine whether the merger and the process that led to it are adequate, and whether th.

GORILLA TECHNOLOGY LANNER LAUNCH CUTTING-EDGE SECURITY CONVERGENCE DEVICES TO TRANSFORM CYBERSECURITY LANDSCAPE

News

— introducing the future of cybersecurity: security convergence devices by gorilla — introducing the future of cybersecurity: security convergence devices by gorilla

CIMPRESS SUCCESSFULLY COMPLETES REPRICING OF TERM LOAN B AND LOWERS ITS COST OF CAPITAL

News

dundalk, ireland--(business wire)--cimpress plc (nasdaq: cmpr), the parent company of vistaprint and other leading print mass customization businesses, today announced the successful repricing of its $773 million usd tranche of its senior secured term loan b (“tlb”). in addition, cimpress upsized the usd tlb tranche by $264 million and used the proceeds to prepay the majority of its euro tlb tranche. cimpress' usd tlb tranche is now $1,037 million, and the euro tranche is €46 million. cimpress.

APTORUM GROUP LIMITED REPORTS 2023 FISCAL YEAR END FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

News

new york & london--(business wire)--aptorum group limited (nasdaq: apm) (“aptorum group” or “we”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announced financial results for the fiscal year ended december 31, 2023, and provided an update on corporate developments. mr. ian huen, chief executive officer and executive director of aptorum group, commented, “throughout 2023, we have maintained a.

LIXTE BIOTECHNOLOGY CO-SPONSORING INTERNATIONAL SCIENTIFIC CONFERENCE ON “THERAPEUTIC OVER-ACTIVATION IN CANCER”

News

recent findings relate to lixte's lead clinical compound, lb-100, to be presented at workshop on may 9 and 10 at harvard's dana farber cancer institute in boston

HERON THERAPEUTICS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS AND HIGHLIGHTS RECENT CORPORATE UPDATES

News

net product sales of $34.7 million, which increased from $29.6 million for the same period in 2023. net loss per share $(0.02), which decreased from $(0.27) for the same period in 2023.

REBORN COFFEE CLOSES MASTER LICENSE AGREEMENT FOR GUANGDONG PROVINCE, CHINA

News

brea, calif., may 08, 2024 (globe newswire) -- reborn coffee inc. (nasdaq: rebn), ("reborn", or the "company"), a california-based retailer of specialty coffee, today announced a significant expansion into the china market through a strategic master license agreement with iaid co., ltd.

PROXIMIC BY COMSCORE RECOGNIZED IN ADEXCHANGER'S 2024 TOP 50 PROGRAMMATIC POWER PLAYERS LIST

News

new york, may 06, 2024 (globe newswire) -- proximic by comscore, a division of comscore inc. (nasdaq:scor) and a leading provider of audience and content targeting solutions for programmatic activation, today announced that it has been included in adexchanger's prestigious 2024 programmatic power players list. compiled by one of the advertising industry's leading media authorities, the list spotlights the top agencies and strategic tech partners in the digital advertising industry.

ARCTURUS THERAPEUTICS TO ATTEND UPCOMING INVESTOR & SCIENTIFIC CONFERENCES

News

san diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global messenger rna medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the company will participate in the following investor and scientific conferences: tides usa: oligonucleotide and peptide therapeutics (presentation) thursday, may 16, 2024 (4:45 p.m. et) h.c. wainwright 2nd an.

LEE ENTERPRISES TO PRESENT AT SIDOTI VIRTUAL INVESTOR CONFERENCE

News

davenport, iowa, may 06, 2024 (globe newswire) -- lee enterprises, incorporated (nasdaq: lee) today announced its chief executive officer, kevin mowbray, and chief financial officer, tim millage, will hold a group presentation and host one-on-one meetings with investors at the sidoti may virtual investor conference, taking place on may 8-9, 2024.

AEROVATE THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

News

waltham, mass., may 13, 2024 (globe newswire) -- aerovate therapeutics, inc. (nasdaq: avte), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease, today announced financial results for the quarter ended march 31, 2024, and recent business highlights.

FIRST CAPITAL, INC. REPORTS QUARTERLY EARNINGS

News

corydon, ind., april 26, 2024 (globe newswire) -- first capital, inc. (the “company”) (nasdaq: fcap), the holding company for first harrison bank (the “bank”), today reported net income of $3.0 million, or $0.88 per diluted share, for the quarter ended march 31, 2024, compared to net income of $3.8 million, or $1.14 per diluted share, for the quarter ended march 31, 2023.

FOUR SIXES™ SEASONINGS, BBQ & HOT SAUCES SET TO BRING TEXAS RANCH-INSPIRED FLAVORS TO HOMES ACROSS AMERICA

News

b&g foods partners with legendary ranch to introduce range of western tastes this spring parsippany, n.j. , may 13, 2024 /prnewswire/ -- b&g foods announced today a partnership with four sixes (6666) ranch to introduce four sixes™ seasonings, bbq & hot sauces.